Drugs / Sesderma ZINC Defense™
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05783180 | Jun 2023 | COVID-19 | Jose David Suarez, MD | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sesderma ZINC Defense | “Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™ (Liposomal Bovine Lactoferrin (LbLf) and Liposomal Zn (LZn))” NCT05783180 ↗ |
| Known as | LZn | “Sesderma LACTYFERRIN™ Forte and Sesderma ZINC Defense™ (Liposomal Bovine Lactoferrin (LbLf) and Liposomal Zn (LZn))” NCT05783180 ↗ |
| Known as | Zinc | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05783180 ↗ |